Tresiba (insulin degludec)
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Tresiba (insulin degludec), covering 2015-10-22 to 2015-10-23. Get the full timeline:
Most recent: Clinical Trial Update: Comparison of Explorative Formulation of Insulin Degludec and Insulin Aspart Co-formulation Versus Explorative Formulation of Insulin Degludec and Insulin Aspart Separately Compared With Biphasic Insulin Aspart 30 in Male Subjects With Diabetes [Phase 1]